Navigation Links
Poor in Medical Technology

Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled

... with actionable information for patients who are poor responders to clopidogrel (Plavix(R)). The ... whether tailored antiplatelet therapy for poor responders, identified based on the results of ... increased frequency is the question of whether poor response to antiplatelet therapy, based on a ...

American Lung Association Study to be Published in the 'New England Journal of Medicine' Finds Prescription Heartburn Medication Does Not Control Asthma Symptoms as Previously Thought

... Patients in both groups had similar numbers of poor asthma control episodes, and there were no ... acid reflux does not play a significant role in poor asthma control. Talk with your doctor before ... The primary outcome was the rate of episodes of poor asthma control (EPACs) based on asthma diaries. ...

Gene Abnormality Found to Predict Childhood Leukemia Relapse

... of genetic abnormalities that together predicted poor outcome." The most significant association ... who were treated in the COG study that had a very poor prognosis. The prognostic significance of these ... to alter patients' therapy if they have a very poor response to treatment," said James Downing, M.D., ...

Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL

... May Lead to Overall Survival in Patients with poor Prognostic Factors SAN FRANCISCO, Dec. 9 ... lymphocytic leukemia (CLL) patients who have poor prognostic indicators. These findings were ... 17 (17p deletion), which may indicate a poor prognosis including significantly inferior ...

Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma

... in all patient sub-groups, including those with poor prognostic characteristics, such as advanced age, poor risk cytogenetics and renal impairment. These ... A subset analysis of VcMP treated patients with poor prognostic features, including age >75 years ...

Dacogen(R) (decitabine for injection) Data Presented on a Phase II Clinical Trial in Elderly Patients with Acute Myeloid Leukemia (AML)

... of patients in the trial had intermediate or poor risk cytogenetics (bone marrow tests to identify abnormal chromosomes), which are associated with poor prognoses. Responses were observed across all patients including those with poor risk cytogenetics, those whose AML transformed ...

New Global Survey Exposes Considerable Burden of Fibromyalgia Including Potential Economic Impact

... a chronic widespread pain condition, results in poor quality of life and poses a financial burden on ... Spain, the Netherlands, Mexico and S. Korea. poor Quality of Life for Patients with Fibromyalgia ... worldwide. Fibromyalgia is usually accompanied by poor sleep, stiffness and fatigue along with other ...

Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients

... see impressive responses in older patients with poor prognostic cytogenetic abnormalities when treated ... disorder such as myelodysplastic syndrome (MDS), poor health performance, or intermediate or ... based on the presence of at least one of these poor prognostic factors at baseline. Patients ...

FDA Advisory Committee Votes in Favor of SAPHRIS(R) (asenapine) for Acute Bipolar I Disorder and Acute Schizophrenia

... three in four patients discontinue therapy within 18 months due to either poor tolerability or incomplete efficacy. Metabolic safety, including weight ... to lack of efficacy or side effects, including metabolic side effects. poor tolerability frequently leads to treatment discontinuation even when the ...

PTSD Associated With Higher Alzheimer's/Dementia Risk; Moderate Alcohol Consumption May Lower it

... and the cost of healthcare," Carrillo added. Adults Show a poor Understanding of Alzheimer's Link to Heart Health Risk Factors ... "Our data suggest that American adults have limited knowledge and a poor understanding of factors that have been demonstrated to increase risk for ...

New Poll Finds Disease Prevention is Top Priority for Americans in Health Reform

... $800 billion on health problems that are directly linked to lifestyle and poor health habits each year--about one third of our total health care ... and lowering health care costs." "Spiraling health care costs and poor outcomes will only get worse in the absence of employer action and ...

Medivation Announces Positive New Efficacy Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients

... post-chemotherapy setting are encouraging because these patients have a poor prognosis, surviving on average a year or less -- with no approved ... as hormone-refractory) prostate cancer have few treatment options and a poor prognosis. Overexpression of the androgen receptor is believed to ...

Neurobiological Technologies' Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program

... tumors in North America and Europe; moreover, patient prognosis is very poor and the treatment options are very limited. In addition, the NTI-0303 ... offer significant clinical benefit for metastatic patients, given the very poor options available now for this substantial patient population. We look ...

Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update

... and Figures 2009). Patients with SCLC have few treatment options and a poor prognosis. Effective second-line treatment for SCLC is a major unmet ... prostate cancers. Patients with CRPC have few treatment options and a poor prognosis. About Picoplatin Picoplatin is designed to ...

Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer

... potential predictive power. 20 percent of the 144 patients in the poor prognosis signature group achieved a pCR, whereas none of the patients ... a pCR. After a median follow-up of 25 months, 19 relapses were seen in the poor signature and none in the good signature group. These findings suggest ...

Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests

... The difference in response can range from potential fatal bleeding to poor response." "Given the varying outcomes of targeted therapies for ... of severe or fatal hemoptysis (internal bleeding in the lungs) to overall poor response. Current methods for differentiating squamous from non ...

Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology

... are seen frequently in many types of cancer and have been correlated with poor prognosis in patients with soft-tissue sarcoma, gastric, hepatocellular, ... pAkt were high-grade, advanced stage or had other features associated with poor prognosis. High pAkt is often seen in tumors that are resistant to ...

Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology

... --Complete Remissions Achieved with Voreloxin in poor Risk Frontline Elderly AML and in Combination with Cytarabine in ... agent Phase 2 trial show that voreloxin induces complete remissions in poor risk frontline elderly AML patients who are unlikely to benefit from ...

Young Women Diagnosed with Early-Stage Breast Cancer More Likely to Die than Older Women

... small size on a mammogram." However, Dr. Margenthaler suspected that the poor outcomes of her young patients were related to factors beyond the lack of ... as well, in that Stage IV cancer has already spread and usually has a poor prognosis. Chemotherapy and radiation can help to control symptoms, but a ...

Body Contouring Surgery Risk Rises with Increased Body Mass Index

... important for plastic surgeons to be cognizant of potential predictors of poor outcomes and/or complications that can arise as a result," said Donald ... such as hypertension, diabetes, sleep apnea, cardiovascular disease, and poor healing, that generally accompany it." Very few studies have looked at ...

Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology

... are seen frequently in many types of cancer and have been correlated with poor prognosis in patients with soft-tissue sarcoma, gastric, hepatocellular, ... pAkt were high-grade, advanced stage or had other features associated with poor prognosis. High pAkt is often seen in tumors that are resistant to ...

Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois

... are seen frequently in many types of cancer and have been correlated with poor prognosis in patients with soft-tissue sarcoma, gastric, hepatocellular, ... pAkt were high-grade, advanced stage or had other features associated with poor prognosis. High pAkt is often seen in tumors that are resistant to ...

New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens

... growth factors (VEGF).(4) HER2 overexpression is associated with poor prognosis(5) and reduced overall survival,(6) while VEGF is linked to ... has been reported in a variety of human tumors and is associated with poor prognosis and reduced overall survival. On March 13, 2007, the United ...

St. Jude Gene Study Reveals Basis of Anti-Cancer Drug Resistance in Childhood Leukemia

... five-year, disease-free survival than those with profiles indicating a poor response. To confirm their findings, the researchers also analyzed the ... or other genetic alterations in their leukemia cells that cause such poor response. The findings broadly confirm the value of such sweeping ...

Anti-Cancer Drug CYT997 Update

... compound in specific cancer types with high unmet medical need and poor prognoses. VDAs are a new class of drugs to treat cancer and have ... Unfortunately, many patients relapse and subsequently have very poor prognoses. Experimental therapies which attack GBM blood vessels have ...

Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results

... application to new molecular entities where use may be restricted due to poor bioavailability," said Michael V. Novinski, President and Chief Executive ... of administration or the benefits of these compounds are limited due to poor bioavailability, slow on-set of action or variable absorption. The ...

38.7 Million People Break Guinness World Record for Stand Up Speak Out on International Day for the Eradication of Poverty

... lobbying actions like delegations to politicians on this date, shows the poor are watching how resources are allocated and want to have a say how ... debate how gender exclusion and discrimination impede development in poor countries. -- In Bangladesh just under 850,000 people stood up with the ...

Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center

... treatment of Multiple Myeloma and Metastatic Colon Cancer. STUDY RATIONALE: Activation of the PI3K/AKT pathway has been associated with poor prognosis, or proliferation, in several pediatric tumors such as neuroblastoma, glioblastoma, rhabdomyosarcoma, and medulloblastoma. Perifosine's ...

Neuroscience Researcher Has Positive Message for International Alzheimer's Awareness Week, July 6 - 12: 'Even Though World Economy is Declining, Alzheimer's Research is Advancing'

... that cognitive function could be improved by lowering neuronal calcium concentrations. "We asked 83 healthy volunteers with self-described poor memory to consume a supplement (Prevagen(R), www.prevagen.com ) containing a protein found in jellyfish that buffers calcium by binding to it," ...

Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia

... "We made a significant financial investment in this pioneering effort to develop lestaurtinib for this molecularly targeted patient population with a poor prognosis and few treatment options," said Frank Baldino, Jr., Ph.D., Cephalon founder, chairman and CEO. "Patients with life-threatening diseases ...

New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients

... happen in people using TNF blockers. Contact your doctor immediately if you develop symptoms such as feeling very tired, skin or eyes look yellow, poor appetite or vomiting, or pain on the right side of your stomach. Low blood counts have been seen with people using TNF blockers. If this ...

Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis

... happen in people using TNF blockers. Contact your doctor immediately if you develop symptoms such as feeling very tired, skin or eyes look yellow, poor appetite or vomiting, or pain on the right side of your stomach. Low blood counts have been seen with people using TNF blockers. If this ...

Micromet's Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients

... safety profile observed in this study. These results are particularly important for these patients who are in a disease stage with extremely poor prognosis and for which we lack treatment options except for patients eligible for allogenic stem cell transplantations." "The ALL interim data ...

Large, Long-Term Study Shows Avandia Has No Increased Overall Cardiovascular Risk Compared to Other Commonly Used Diabetes Medicines

... AVANDIA with insulin or nitrates is not recommended. AVANDIA can cause or worsen heart failure. If you have severe heart failure (very poor pumping ability of the heart) you cannot be started on AVANDIA. AVANDIA is also not recommended if you have heart failure with symptoms (such as ...

New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Disease

... or worsening symptoms, such as shortness of breath, swelling of ankles or feet, or sudden weight gain. Reactivation of HBV - feeling unwell, poor appetite, tiredness, fever, skin rash and/or joint pain. Liver injury - jaundice (yellow skin and eyes), dark brown urine, right-sided ...

Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL)

... even at surprisingly low doses, in a heavily pre-treated patient population most of whom harbored genetic lesions known to be associated with poor response to standard therapies," said Peter Thompson, M.D., FACP, president, CEO and chairman of Trubion. "These data suggest that this novel, ...

Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients

... disease for 20 weeks (5 mos.). These specific tumor types are associated with aberrations of the PI3K pathway that commonly lead to resistance and poor prognostic outcomes. Pharmacodynamic analysis of tumor tissue confirmed inhibition of the PI3K pathway by complete absence of a downstream ...

Celladon Corporation Announces Presentation of First-in-Human Gene Transfer to Treat Heart Failure at the 12th Annual Meeting of the American Society of Gene Therapy

... underpinning of heart failure is the depletion of SERCA2a enzyme in heart muscle cells, which results in abnormal intracellular calcium cycling and poor contractility," said Zsebo. "Our research shows that recombinant adeno-associated viral vectors (AAV) are ideal for restoring SERCA2a enzyme ...

Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop

... suggested that patients with frequent HAE attacks, severe attacks, past laryngeal attacks, excessive loss of work or school, significant anxiety and poor quality of life could be considered for prophylaxis therapy, especially for those that fail, are intolerant, have adverse events or are not ...

MitraClip(R) Therapy Data Demonstrate Clinical Benefit in High-Risk Patients With Mitral Regurgitation

... usually because of advanced age and co-morbidities, which consequently limit their treatment options. Without MR reduction, these patients have a poor quality of life, are frequently hospitalized for heart failure and have reduced survival. The High Risk Registry data showed similar 30-day ...
Other Contents
(Date:12/10/2014)... , Dec. 9, 2014  Wake Forest Baptist Medical Center ... for its School of Medicine. Funding for this $50 ... campaign that will be publicly launched next summer. ... in the former 60 series R.J. Reynolds Tobacco Company ... Construction will begin immediately with plans to be ready ...
(Date:12/5/2014)... Dec. 4, 2014  Tute Genomics, a leader in ... in Series A1 funding led by UK-based Eurovestech. Peak ... in the investment round. "We are at ... adopts next-generation sequencing and seeks new approaches for the ... Robison , MD MBA, and CEO of Tute Genomics. ...
(Date:11/21/2014)... 2014  Earlier this year Donald Spector , ... one of the most prolific inventors in the world, ... from Smartphones to third party agencies. Spector envisioned this ... of the earliest known patents in this area. Now ... military, child care, elder care and hospital applications. This ...
Breaking Biology News(10 mins):Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4
(Date:12/26/2014)... London, England (PRWEB) December 26, 2014 ... to take place March 24-28, 2015 in Rome, Italy ... years' line-up includes workshops on a wide ... insomnia, as well as peak performance training in athletes. ... from around the world. , Biofeedback monitoring allows clients ...
(Date:12/26/2014)... Pentec Health, Inc. number fourteen on the ... for 2014. The awards program, created in 2000, is ... in the country. The program is a public/private partnership ... and Economic Development, the Pennsylvania State Council of the ... Business Journal. , Charlie Wilson, Vice President ...
(Date:12/25/2014)... 26, 2014 This is a professional ... global Sterilizers industry with a focus on the Chinese ... status of the Sterilizers manufacturers and is a valuable ... interested in the industry. This report provides a basic ... manufacturing technology. In this part, the report presents the ...
(Date:12/25/2014)... York, New York (PRWEB) December 25, 2014 ... the 2010 DePuy ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) ... LLP reports. According to an Order issued in the ... 20th, the Court will convene an open conference on ... Building and United States Courthouse in West Palm Beach, ...
(Date:12/25/2014)... December 25, 2014 The short film “Color ... created in honor of a true 9/11 hero, Welles Remy ... festivals including the 24 hours of Nuremberg International Short Film ... , Actress, screenwriter and director Luciana Lagana ... film together with her husband, Gregory Graham - ...
Breaking Medicine News(10 mins):Health News:Final Workshop Line-up Announced for 18th Annual Biofeedback Conference in Rome, Italy 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 3Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3
Other TagsOther Tags